| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.6M | -81.3% |
| SG&A Expense | $4.1M | -57.3% |
| Operating Income | -$16.2M | +67.0% |
| Interest Expense | $5K | -99.9% |
| Net Income | -$15.8M | +69.5% |
| EPS (Basic) | -$38.57 | -542.8% |
| EPS (Diluted) | -$38.57 | -542.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.8M | +9.7% |
| Current Assets | $8.6M | -24.1% |
| Total Assets | $9.3M | -47.5% |
| Current Liabilities | $12.6M | -18.0% |
| Total Liabilities | $13.2M | -25.2% |
| Stockholders' Equity | -$3.9M | -3248.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.4M | +76.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $11.3M | +143.2% |
| Free Cash Flow | -$11.4M | +77.0% |